Molecular Biomarkers in Peri-Implant Health and Disease: A Cross-Sectional Pilot Study
Open Access
- 29 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 9802
Abstract
Background: The aim of this feasibility study was to investigate the concentration level of CCL-20/MIP-3α, BAFF/BLyS, IL-23, RANKL, and Osteoprotegerin in the Peri-Implant Crevicular Fluid (PICF), from patients diagnosed with peri-implant mucositis and peri-implantitis, and to compare them with PICF from patients with healthy implants. Methods: Participants with at least one dental implant with healthy peri-implant tissues, peri-implant mucositis, or peri-implantitis were included. PICF was collected using paper strips from healthy and diseased peri-implant sites (n = 19). Biomarker levels were analyzed using a custom Multiplex ELISA Assay Kit. Results: In comparison to peri-implant health, the peri-implant mucositis group showed an increased concentration of CCL-20 MIP-3α, BAFF/BLyS, IL-23, RANKL, and Osteoprotegerin. The peri-implantitis group had the lowest median concentration of Osteoprotegerin (1963 ng/mL); this group had a similar concentration of RANKL (640.84 ng/mL) when compared to the peri-implant health group. BAFF/BLyS (17.06 ng/mL) showed the highest concentration in the peri-implantitis group. Conclusions: This feasibility study suggests that IL-23 and RANKL may help to elucidate the pathogenesis during the conversion from peri-implant health to peri-implantitis. Further research is required in BAFF/BLyS for the early diagnosis of peri-implantitis.Keywords
Funding Information
- National Agency for Research and Development of Chile (ANID) (No. REDI170658)
This publication has 38 references indexed in Scilit:
- Bone loss biomarkers associated with peri‐implantitis. A cross‐sectional studyClinical Oral Implants Research, 2012
- Evidence for osteocyte regulation of bone homeostasis through RANKL expressionNature Medicine, 2011
- Reversibility of experimental peri‐implant mucositis compared with experimental gingivitis in humansClinical Oral Implants Research, 2011
- A comprehensive and critical review of dental implant prognosis in periodontally compromised partially edentulous patientsClinical Oral Implants Research, 2007
- B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal DiseaseThe American Journal of Pathology, 2006
- Osteoprotegerin Ligand Regulates Osteoclast Adherence to the Bone Surface in Mouse CalvariaBiochemical and Biophysical Research Communications, 2000
- Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in VivoThe American Journal of Pathology, 2000
- The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE ReceptorJournal of Biological Chemistry, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Experimentally induced peri‐implant mucositis. A clinical study in humans.Clinical Oral Implants Research, 1994